Quidel Current Ratio 2006-2019 | QDEL

Quidel current ratio from 2006 to 2019. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
Quidel Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2019-03-31 $0.21B $0.16B 1.33
2018-12-31 $0.19B $0.16B 1.21
2018-09-30 $0.20B $0.16B 1.26
2018-06-30 $0.17B $0.15B 1.10
2018-03-31 $0.27B $0.20B 1.36
2017-12-31 $0.33B $0.13B 2.58
2017-09-30 $0.24B $0.04B 6.28
2017-06-30 $0.23B $0.03B 7.19
2017-03-31 $0.25B $0.03B 8.41
2016-12-31 $0.23B $0.03B 6.71
2016-09-30 $0.21B $0.03B 8.23
2016-06-30 $0.20B $0.02B 8.60
2016-03-31 $0.21B $0.03B 7.46
2015-12-31 $0.24B $0.03B 7.81
2015-09-30 $0.25B $0.04B 6.91
2015-06-30 $0.26B $0.03B 7.62
2015-03-31 $0.29B $0.04B 7.90
2014-12-31 $0.27B $0.04B 7.54
2014-09-30 $0.09B $0.03B 2.88
2014-06-30 $0.07B $0.02B 3.67
2014-03-31 $0.08B $0.02B 3.42
2013-12-31 $0.08B $0.02B 3.28
2013-09-30 $0.07B $0.02B 3.33
2013-06-30 $0.07B $0.02B 3.90
2013-03-31 $0.09B $0.02B 4.01
2012-12-31 $0.08B $0.02B 3.32
2012-09-30 $0.07B $0.02B 4.48
2012-06-30 $0.06B $0.01B 4.98
2012-03-31 $0.07B $0.02B 4.44
2011-12-31 $0.10B $0.03B 3.17
2011-09-30 $0.09B $0.03B 2.74
2011-06-30 $0.10B $0.02B 6.42
2011-03-31 $0.11B $0.02B 5.53
2010-12-31 $0.06B $0.02B 3.55
2010-09-30 $0.06B $0.02B 3.24
2010-06-30 $0.07B $0.02B 3.81
2010-03-31 $0.08B $0.02B 4.11
2009-12-31 $0.13B $0.03B 4.28
2009-09-30 $0.11B $0.02B 4.68
2009-06-30 $0.08B $0.01B 7.89
2009-03-31 $0.08B $0.01B 8.08
2008-12-31 $0.10B $0.02B 6.55
2008-09-30 $0.11B $0.02B 6.87
2008-06-30 $0.09B $0.01B 7.95
2008-03-31 $0.10B $0.01B 6.60
2007-12-31 $0.09B $0.02B 5.14
2007-09-30 $0.07B $0.01B 4.89
2007-06-30 $0.06B $0.01B 4.86
2007-03-31 $0.06B $0.01B 5.17
2006-12-31 $0.07B $0.02B 4.63
2006-09-30 $0.06B $0.01B 4.03
2006-06-30 $0.06B $0.01B 5.05
2006-03-31 $0.06B $0.01B 5.09
2005-12-31 $0.06B $0.02B 3.65
2005-09-30 $0.05B $0.01B 3.74
2005-06-30 $0.04B $0.01B 6.00
2005-03-31 $0.06B $0.03B 2.34
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $2.309B $0.522B
Quidel Corp. discovers, develops, manufactures and markets point-of-care, rapid diagnostic tests for detection of medical conditions and illnesses. These products provide accurate, rapid and cost-effective diagnostic information for acute and chronic conditions that affect women's health throughout the phases of their lives including reproductive status, pregnancy management and osteoporosis. Quidel also provides point-of-care diagnostics for infectious diseases, including influenza A and B, strep throat, H. pylori infection, chlamydia and infectious mononucleosis.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $147.856B 28.70
Medtronic (MDT) Ireland $133.874B 19.12
Stryker (SYK) United States $76.669B 27.36
Boston Scientific (BSX) United States $59.033B 28.30
Baxter (BAX) United States $41.839B 26.37
EssilorLuxottica Societe Anonyme (ESLOY) France $29.060B 0.00
Coloplast (CLPBY) Denmark $25.618B 40.90
Zimmer Biomet Holdings (ZBH) United States $24.965B 16.04
Lonza Group Ag (LZAGY) Switzerland $24.947B 0.00
Terumo (TRUMY) Japan $23.393B 26.90
Smith & Nephew SNATS (SNN) United Kingdom $19.274B 0.00
ResMed (RMD) United States $17.745B 33.90
Canopy Growth (CGC) Canada $12.161B 0.00
Sunny Optical Technology (SNPTF) China $12.027B 0.00
Bio-Rad Laboratories (BIO) United States $9.308B 49.34
William Demant Holdings (WILYY) Denmark $7.651B 0.00
Insulet (PODD) United States $7.203B 524.78
Aurora Cannabis (ACB) Canada $7.109B 70.10
Perrigo (PRGO) Ireland $7.004B 11.84
Hill-Rom Holdings (HRC) United States $6.993B 21.20
GN STORE NORD (GNNDY) Denmark $6.409B 32.73
Haemonetics (HAE) United States $6.325B 51.63
ICU Medical (ICUI) United States $5.135B 30.64
GW Pharmaceuticals (GWPH) United Kingdom $5.057B 0.00
Neogen (NEOG) United States $3.349B 54.45
NuVasive (NUVA) United States $2.982B 24.36
Hutchison China MediTech (HCM) China $2.925B 0.00
Agios Pharmaceuticals (AGIO) United States $2.711B 0.00
National Vision Holdings (EYE) United States $2.420B 51.57
Cardiovascular Systems (CSII) United States $1.598B 917.80
Aphria (APHA) $1.579B 0.00
Phibro Animal Health (PAHC) United States $1.229B 18.41
AtriCure (ATRC) United States $1.218B 0.00
VAREX IMAGING (VREX) United States $1.187B 25.19
Lantheus Holdings (LNTH) United States $1.089B 28.93
NanoString Technologies (NSTG) United States $1.056B 0.00
PetIQ (PETQ) United States $0.994B 24.14
MacroGenics (MGNX) United States $0.777B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.765B 21.47
Cerus (CERS) United States $0.758B 0.00
Quanterix (QTRX) United States $0.753B 0.00
Omeros (OMER) United States $0.750B 0.00
TG Therapeutics (TGTX) United States $0.698B 0.00
LeMaitre Vascular (LMAT) United States $0.572B 27.71
Surmodics (SRDX) United States $0.543B 78.88
OraSure Technologies (OSUR) United States $0.531B 24.43
Meridian Bioscience (VIVO) United States $0.476B 14.56
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.404B 0.00
Vapotherm (VAPO) United States $0.345B 0.00
Utah Medical Products (UTMD) United States $0.320B 22.13
BioLife Solutions (BLFS) United States $0.304B 95.24
Zynex (ZYXI) United States $0.250B 25.67
Bovie Medical (APYX) United States $0.236B 0.00
Cytosorbents (CTSO) United States $0.227B 0.00
Owens & Minor (OMI) United States $0.198B 4.20
Chimerix (CMRX) United States $0.188B 0.00
United Health Products (UEEC) United States $0.175B 0.00
Rockwell Medical (RMTI) United States $0.170B 0.00
Female Health (VERU) United States $0.146B 0.00
Fonar (FONR) United States $0.139B 7.33
Chembio Diagnostics (CEMI) United States $0.098B 0.00
United-Guardian (UG) United States $0.094B 20.65
InfuSystems Holdings (INFU) United States $0.090B 0.00
Surface Oncology (SURF) United States $0.075B 0.00
Trinity Biotech (TRIB) Ireland $0.060B 20.75
Oramed Pharmaceuticals (ORMP) United States $0.058B 0.00
MRI INTERVENTNS (MRIC) United States $0.052B 0.00